当前位置:首页 - 行情中心 - 达安基因(002030) - 财务分析 - 现金流量表

达安基因

(002030)

  

流通市值:92.07亿  总市值:92.07亿
流通股本:14.03亿   总股本:14.03亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金486,896,849.46240,398,300.441,439,801,857.031,009,370,476.74
  收到的税费返还284,910.9973,494.82580,125.78151,191.31
  收到其他与经营活动有关的现金358,999,397.28186,932,530.27976,791,604.26639,451,782.97
  经营活动现金流入小计846,181,157.73427,404,325.532,417,173,587.071,648,973,451.02
  购买商品、接受劳务支付的现金206,122,856.99107,300,663.12536,939,916.15371,212,449.86
  支付给职工以及为职工支付的现金245,673,189.9156,989,994.6468,265,875.59443,395,771.9
  支付的各项税费21,940,344.857,892,107.3951,340,716.2730,609,875.6
  支付其他与经营活动有关的现金383,087,370.51191,915,427.671,060,294,362.46671,335,494.44
  经营活动现金流出小计856,823,762.25464,098,192.782,116,840,870.471,516,553,591.8
  经营活动产生的现金流量净额-10,642,604.52-36,693,867.25300,332,716.6132,419,859.22
二、投资活动产生的现金流量:
  收回投资收到的现金239,883,045.68130,370,000399,644,582.26231,574,582.26
  取得投资收益收到的现金2,878,071.05578,609.0628,864,738.9620,575,137.08
  处置固定资产、无形资产和其他长期资产收回的现金净额245,347.3813,067.62106,176.1286,500
  处置子公司及其他营业单位收到的现金净额0023.5823.58
  收到的其他与投资活动有关的现金600,000,000450,000,087.011,143,066,927.84430,000,000.22
  投资活动现金流入小计843,006,464.11580,961,763.691,571,682,448.76682,236,243.14
  购建固定资产、无形资产和其他长期资产支付的现金116,290,768.4232,733,690.51174,413,084.9494,077,675.37
  投资支付的现金569,513,379.04104,513,379.04371,201,735.64301,191,690.2
  支付其他与投资活动有关的现金500,000,000400,000,0001,243,460,500450,000,000
  投资活动现金流出小计1,185,804,147.46537,247,069.551,789,075,320.58845,269,365.57
  投资活动产生的现金流量净额-342,797,683.3543,714,694.14-217,392,871.82-163,033,122.43
三、筹资活动产生的现金流量:
  取得借款收到的现金43,360,867.527,790,010147,852,756.8591,580,725.05
  收到其他与筹资活动有关的现金9,900,000046,800,00046,800,000
  筹资活动现金流入小计53,260,867.527,790,010194,652,756.85138,380,725.05
  偿还债务支付的现金103,633,32653,647,326357,667,421.92301,634,236.62
  分配股利、利润或偿付利息支付的现金2,042,491.431,025,509.7127,879,255.9527,319,938.57
  支付其他与筹资活动有关的现金743,531.38815,335.6915,061,103.071,457,561.19
  筹资活动现金流出小计106,419,348.8155,488,171.4400,607,780.94330,411,736.38
  筹资活动产生的现金流量净额-53,158,481.31-27,698,161.4-205,955,024.09-192,031,011.33
四、汇率变动对现金及现金等价物的影响-429,638.66-100,827.821,112,584.86-341,712.04
五、现金及现金等价物净增加额-407,028,407.84-20,778,162.33-121,902,594.45-222,985,986.58
  加:期初现金及现金等价物余额867,371,878.26867,371,878.26989,274,472.71989,274,472.71
  期末现金及现金等价物余额460,343,470.42846,593,715.93867,371,878.26766,288,486.13
补充资料:
  净利润-190,124,632.54--939,112,861.02-
  资产减值准备5,828,434.13-75,039,742.89-
  固定资产和投资性房地产折旧92,464,575.59-227,544,629.61-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧92,464,575.59-227,544,629.61-
  无形资产摊销69,142,480.83-116,514,359.09-
  长期待摊费用摊销5,619,533.75-11,371,952.54-
  处置固定资产、无形资产和其他长期资产的损失-476,575.74--9,096,715.23-
  固定资产报废损失4,075,401.17-1,762,355.5-
  公允价值变动损失-85,568,280.89-175,745,759.4-
  财务费用2,100,374.22-9,744,538.33-
  投资损失-4,777,877.08-253,838,060.16-
  递延所得税-33,697,862.43--148,113,569.96-
  其中:递延所得税资产减少-47,072,964.16--129,498,953.04-
    递延所得税负债增加13,375,101.73--18,614,616.92-
  存货的减少11,169,125.98-80,688,743.16-
  经营性应收项目的减少133,877,198.72-745,693,804.95-
  经营性应付项目的增加-193,221,927.97--715,417,059.2-
  其他0-0-
  债务转为资本0-0-
  一年内到期的可转换公司债券0-0-
  融资租入固定资产0-0-
  不涉及现金收支的投资和筹资活动金额其他项目--13,781,763.55-
  现金的期末余额460,343,470.42-867,371,878.26-
  减:现金的期初余额867,371,878.26-989,274,472.71-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额-407,028,407.84--121,902,594.45-
公告日期2025-08-302025-04-302025-03-292024-10-31
审计意见(境内)标准无保留意见
TOP↑